The U.S. Centers for Disease Control and Prevention (CDC) awarded a $4,989,475 cooperative agreement to Aids United under the Capacity Building Assistance (CBA) for High-Impact HIV Prevention program (CFDA 93.834). This five-year award, running from August 2024 to March 2029, supports Aids United's efforts to build the capacity of healthcare organizations, community-based organizations, and state/local health departments to implement high-impact HIV prevention initiatives. Key services...
This $7,888,424 Cooperative Agreement award, issued by the Centers for Disease Control and Prevention (CDC) under the Capacity Building Assistance (CBA) for High-Impact HIV Prevention program (CFDA 93.834), provides funding to HealthHIV, a national non-profit organization based in Washington, DC. The award supports two key components: 1) eLearning training for high-impact HIV prevention programs, and 2) organization/workforce development and management for community-based organizations. The...
This federal Cooperative Agreement award from the National Center for HIV/AIDS, part of the Centers for Disease Control and Prevention (CDC), provides $4,989,475.00 in funding for the "Capacity Building Assistance (CBA) for High-Impact HIV Prevention Programs to End the HIV Epidemic in the United States - Component D: Technical Assistance for High-Impact HIV Prevention Programs" (CFDA 93.834). The primary awardee, the City & County of San Francisco Public Health Department, will...
The U.S. Department of Health and Human Services, Centers for Disease Control and Prevention (CDC) awarded a $4,989,475 Cooperative Agreement to Public Health Foundation Enterprises, Inc. (doing business as Heluna Health) under the Capacity Building Assistance (CBA) for High-Impact HIV Prevention program (CFDA 93.834). The five-year award, starting on August 30, 2024, aims to build the capacity of healthcare organizations, community-based organizations, and state/local health departments to...
The federal Cooperative Agreement award provides $4,989,475.00 to The Regents of the University of California, San Francisco (UCSF) to deliver technical assistance and capacity building services under the Centers for Disease Control and Prevention's (CDC) Capacity Building Assistance (CBA) for High-Impact HIV Prevention program (CFDA 93.834). The award, which runs from August 2024 to March 2029, supports UCSF in providing a range of services to healthcare organizations, community-based...
The Albuquerque Area Indian Health Board Inc. (AAIHB) has been awarded a $4,989,480.00 Cooperative Agreement from the Centers for Disease Control and Prevention (CDC) under the Capacity Building Assistance (CBA) for High-Impact HIV Prevention program (CFDA 93.834). The award, with a performance period from August 30, 2024 to March 31, 2029, will enable AAIHB to serve as the National Native HIV Network Technical Assistance Center. In this capacity, AAIHB will provide comprehensive technical...
The federal Cooperative Agreement award, with ID NU65PS923778, was provided by the Centers for Disease Control and Prevention (CDC) under the Capacity Building Assistance (CBA) for High-Impact HIV Prevention program (CFDA 93.834). The $4,989,476.00 award, with a performance period from August 2024 to March 2029, supports Community Education Group, Inc., a Black American-owned non-profit organization, to deliver comprehensive technical assistance, training, and capacity building services to...
The Latino Commission On Aids Inc. was awarded a $4,989,475.00 Cooperative Agreement by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) under the Capacity Building Assistance (CBA) for High-Impact HIV Prevention program (CFDA 93.834). The award, which runs from August 2024 to March 2029, supports the organization's efforts to reduce HIV morbidity and mortality through capacity building initiatives for healthcare organizations, community-based...
The National Alliance of State & Territorial AIDS Directors (NASTAD) has been awarded a $6,166,318 Cooperative Agreement under the Centers for Disease Control and Prevention's (CDC) Capacity Building Assistance (CBA) for High-Impact HIV Prevention program (CFDA 93.834). This five-year award, effective from September 30, 2024 to March 31, 2029, will support NASTAD in providing technical assistance, training, and capacity building services to healthcare organizations, community-based...
The University of Rochester was awarded a five-year Cooperative Agreement from the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) under the Capacity Building Assistance (CBA) for High-Impact HIV Prevention program (CFDA 93.834). The $4,989,476 award, which commenced on August 30, 2024 and runs through March 31, 2029, supports the university's efforts to build the capacity of healthcare organizations, community-based organizations, and state/local...
The U.S. Centers for Disease Control and Prevention (CDC) awarded a $15,351,606 Cooperative Agreement under the Capacity Building Assistance (CBA) for High-Impact HIV Prevention program (CFDA 93.834) to Cicatelli Associates, Inc. (CAI), a global non-profit organization based in New York City. This five-year award, running from August 2024 to March 2029, will fund CAI to provide capacity building, training, and technical assistance to healthcare organizations, community-based organizations, and state/local health departments across the United States. The CBA program aims to reduce HIV morbidity and mortality through strategic prevention efforts. Under this award, CAI will deliver a range of services including eLearning training, organizational development support, and coordination of a national CBA provider network to strengthen the interdisciplinary HIV prevention workforce.